Therapy News and Research

RSS

Many people with severe rheumatoid arthritis failing to take expensive medication

Large numbers of people with severe rheumatoid arthritis are failing to take expensive medication as prescribed, according to a new multi-centre study led by researchers in Manchester.

From The University of Manchester 28 Aug 2014

HICCC receives $18 million grant from the National Cancer Institute

Outstanding basic research, a growing focus on translating discoveries into treatments, and a dedication to patient care have earned the Herbert Irving Comprehensive Cancer Center (HICCC) of Columbia University Medical Center (CUMC) and NewYork-Presbyterian Hospital an $18 million, five-year Cancer Center Support Grant from the National Cancer Institute (NCI).

28 Aug 2014

Sequent Medical initiates patient enrollment in IDE pivotal trial of WEB Aneurysm Embolization System

Sequent Medical, Inc. announced today that it has initiated patient enrollment in an Investigational Device Exemption ("IDE") pivotal trial to evaluate the safety and effectiveness of the WEB Aneurysm Embolization System ("WEB").

28 Aug 2014

Analysis reveals fascinating insights into client and therapist personalities and psychotherapy process

During this study in Psychotherapy Research, the authors set out to interpret the content and consequences of client's dreams about their therapists and vice versa. The analysis reveals some fascinating insights into client and therapist personalities, therapeutic relationships, and the psychotherapy process.

28 Aug 2014

Researchers report possible therapy that could help treat patients infected with SUDV

Ebola is a rare, but deadly disease that exists as five strains, none of which have approved therapies.

28 Aug 2014

Scientists solve mystery of why specific signaling pathway can be linked with alcohol dependence

Scientists at The Scripps Research Institute (TSRI) have solved the mystery of why a specific signaling pathway can be associated with alcohol dependence.

28 Aug 2014

New biomarker may improve diagnosis of early-stage rheumatoid arthritis

A novel biomarker for rheumatoid arthritis (RA) has significant potential to help physicians better identify early-stage disease, when treatment can often arrest further disease progression and disability, according to a new study in The Journal of Rheumatology.

From Quest Diagnostics 28 Aug 2014

Scientists alter emotional associations of specific memories

By manipulating neural circuits in the brain of mice, scientists have altered the emotional associations of specific memories.

28 Aug 2014

Contaminated blood cultures can serve as diagnostic predictor for more targeted antibiotics

Some 30 percent of all positive hospital blood culture samples are discarded every day because they're "contaminated" - they reflect the presence of skin germs instead of specific disease-causing bacteria.

28 Aug 2014

Experimental drug shows promise as viable treatment for anemia of inflammation

An experimental drug designed to help regulate the blood's iron supply shows promise as a viable first treatment for anemia of inflammation, according to results from the first human study of the treatment published online today in Blood, the Journal of the American Society of Hematology.

28 Aug 2014

Advanced statistical approach evaluates gene-environmental interactions that contribute to disease

Dartmouth cancer researchers developed and tested an advanced statistical model to evaluate the genetic and environmental interactions that contribute to disease as published yesterday in Human Genetics.

28 Aug 2014

TxCell announces five new patents for core technology and ASTrIA platform

TxCell SA, a biotech developing innovative, personalized cell-based immunotherapies using antigen-specific regulatory T-cells (Ag-Tregs) for chronic inflammatory and autoimmune diseases, today announces that five new patents for their technologies have been issued in the Unites States, Asia and Australia since the beginning of 2014.

27 Aug 2014

Meridian Health joins "The Baton Pass" to spread message of hope

Meridian Health, a leading health care system in New Jersey, joined a national movement called "The Baton Pass™" to help raise funds for innovative cancer research and spread a message of hope.

27 Aug 2014

Findings encourage investigation on fear, safety and sleep in human PTSD

The effectiveness of post-traumatic stress disorder (PTSD) treatment may hinge significantly upon sleep quality, report researchers at the University of California, San Diego School of Medicine and Veterans Affairs San Diego Healthcare System in a paper published today in the Journal of Neuroscience.

27 Aug 2014

Scientists pave way for improved tools to diagnose, predict and monitor cancer

Scientists have shown how to better identify and measure vital molecules that control cell behaviour - paving the way for improved tools for diagnosis, prediction and monitoring of cancer.

From The University of Manchester 27 Aug 2014

New guidelines can improve the way statin drugs prescribed to patients at cardiovascular risk

New national guidelines can improve the way statin drugs are prescribed to patients at risk for cardiovascular disease, a Yale University study has found.

27 Aug 2014

Versatile nanoparticles offer wide variety of diagnostic and therapeutic applications

Kit Lam and colleagues from UC Davis and other institutions have created dynamic nanoparticles (NPs) that could provide an arsenal of applications to diagnose and treat cancer.

27 Aug 2014

Genetic changes in patients with Crohn's disease could hold clues to fighting illness

Genetic changes that occur in patients with the bowel condition Crohn's disease could hold clues to fighting the illness.

27 Aug 2014

Scientists find that DNA repair drug could help treat leukaemia, other cancers

A team of scientists led by Research Associate Professor Motomi Osato and Professor Yoshiaki Ito from the Cancer Science Institute of Singapore at the National University of Singapore found that a drug originally designed for killing a limited type of cancer cells with DNA repair defects could potentially be used to treat leukaemia and other cancers.

26 Aug 2014

Ruthigen gets DMC recommendation to begin RUT58-60 Phase 1/2 clinical trial

Ruthigen Inc., a biopharmaceutical company focused on improving patient outcomes and reducing healthcare costs in invasive procedures, has announced that its lead drug candidate, RUT58-60, has received a recommendation from the Data Monitoring Committee to begin enrolling patients in the Company's planned Phase 1/2 clinical trial.

26 Aug 2014

Therapy News and Research

Many people with severe rheumatoid arthritis failing to take expensive medication

HICCC receives $18 million grant from the National Cancer Institute

Sequent Medical initiates patient enrollment in IDE pivotal trial of WEB Aneurysm Embolization System

Analysis reveals fascinating insights into client and therapist personalities and psychotherapy process

Researchers report possible therapy that could help treat patients infected with SUDV

Scientists solve mystery of why specific signaling pathway can be linked with alcohol dependence

New biomarker may improve diagnosis of early-stage rheumatoid arthritis

Scientists alter emotional associations of specific memories

Contaminated blood cultures can serve as diagnostic predictor for more targeted antibiotics

Experimental drug shows promise as viable treatment for anemia of inflammation

Advanced statistical approach evaluates gene-environmental interactions that contribute to disease

TxCell announces five new patents for core technology and ASTrIA platform

Meridian Health joins "The Baton Pass" to spread message of hope

Findings encourage investigation on fear, safety and sleep in human PTSD

Scientists pave way for improved tools to diagnose, predict and monitor cancer

New guidelines can improve the way statin drugs prescribed to patients at cardiovascular risk

Versatile nanoparticles offer wide variety of diagnostic and therapeutic applications

Genetic changes in patients with Crohn's disease could hold clues to fighting illness

Scientists find that DNA repair drug could help treat leukaemia, other cancers

Ruthigen gets DMC recommendation to begin RUT58-60 Phase 1/2 clinical trial

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News